Edition:
United Kingdom

People: China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.21HKD
26 Jun 2019
Change (% chg)

HK$-0.01 (-3.21%)
Prev Close
HK$0.22
Open
HK$0.19
Day's High
HK$0.21
Day's Low
HK$0.19
Volume
95,000
Avg. Vol
1,338,431
52-wk High
HK$3.60
52-wk Low
HK$0.18

Wang, Xuejun 

Mr. Wang Xuejun is Chief Executive Officer, Executive Director of the Company. is a master of business administration from Nankai University. He was an executive deputy general manager of Vcanbio Cell & Gene Engineering Corp., Ltd. (stock code on the Shanghai Stock Exchange: SH600645), general manager of marketing center of Union Stemcell & Gene Engineering Co., Ltd and head of its subsidiary, and a director and general manager of certain subsidiaries of Heze Biotech Co., Ltd. He was also a director and general manager of Heze Biotech Co., Ltd. and a doctor at Tianjin Rehabilitation Center.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --